MedTrace Logo

Amniotic Fluid Analysis

NCT06131684 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-11-14

No results posted yet for this study

Summary

This is a prospective study that will aid in ensuring the feasibility of timely and correct aspiration of amniotic fluid by study research team that include the clinical team taking care of the patient during her labor, timely transport and interpretation of specimens. It will also assist in providing information for the computation of necessary statistical measures (e.g. sample size, power analysis, etc.) for the study cohorts that lack the needed data in the medical literature.

Conditions

  • Obstetric Labor Complications

Interventions

DEVICE

Intrauterine pressure catheter (IUPC) present

Amniotic fluid will be analyzed every 3 hours for the duration of labor for patients who require an IUPC through the standard of care.

DEVICE

Intrauterine pressure catheter (IUPC) absent

Patients that do not require an IUPC through the standard of care will not have amniotic fluid analyzed.

Sponsors & Collaborators

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Adam Crosland, MD · Oregon Health and Science University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06131684 on ClinicalTrials.gov